235 related articles for article (PubMed ID: 24573984)
1. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
7. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
11. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
12. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
Yildiz I; Ozdemir N; Celkan T; Soylu S; Karaman S; Canbolat A; Dogru O; Erginoz E; Apak H
Pediatr Hematol Oncol; 2015; 32(6):406-14. PubMed ID: 26154620
[TBL] [Abstract][Full Text] [Related]
13. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
[TBL] [Abstract][Full Text] [Related]
15. Biological stratification of clinical disease courses in childhood immune thrombocytopenia.
Schmidt DE; Heitink-Pollé KMJ; Mertens B; Porcelijn L; Kapur R; van der Schoot CE; Vidarsson G; van der Bom JG; Bruin MCA; de Haas M
J Thromb Haemost; 2021 Apr; 19(4):1071-1081. PubMed ID: 33386662
[TBL] [Abstract][Full Text] [Related]
16. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP).
Sturgill MG; Nagabandi SR; Drachtman RA; Ettinger AG; Rubin J; Ettinger LJ
J Pediatr Hematol Oncol; 1997; 19(6):523-5. PubMed ID: 9407938
[TBL] [Abstract][Full Text] [Related]
17. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
20. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
